Jeffrey S. Ross, MD

Articles by Jeffrey S. Ross, MD

42 Tissue and Liquid Biopsy–Based Comprehensive Genomic Profiling Reveal Mechanisms of Therapy Resistance and Rare Targetable Alterations in Breast Cancer

ByEthan Sokol,Smruthy Sivakumar,Dexter X. Jin,Hanna Tukachinsky,Karthikeyan Murugesan,Dean Pavlick,Jeffrey S. Ross, MD,Garrett M. Frampton,Geoffrey R. Oxnard, MD,Priti S. Hegde

April 18th 2022

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis

ByJeffrey S. Ross, MD

June 1st 1996

This review focuses on the clinical utility and potential value of cell cycle analysis and DNA ploidy interpretation in the diagnosis of human tumors, the application of these techniques to cytologic diagnosis, and their capability

Latest Updated Articles

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis
June 1st 1996

Jeffrey S. Ross, MD

Articles by Jeffrey S. Ross, MD

42 Tissue and Liquid Biopsy–Based Comprehensive Genomic Profiling Reveal Mechanisms of Therapy Resistance and Rare Targetable Alterations in Breast Cancer

DNA Ploidy and Cell Cycle Analysis in Cancer Diagnosis and Prognosis

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Lutetium Lu 177 Dotatate Injection for GEP-NETs

FDA Approves Topical Gel for Superficial Basal Cell Carcinoma

SOHO 2026 Sessions Reveal Key Updates Across Leukemia Populations

Trastuzumab Botidotin Prolongs PFS vs T-DM1 in HER2+ Advanced Breast Cancer

Camizestrant Combo Misses PFS End Point in First-Line ER+/HER2– Breast Cancer